Volume 12, Number 8—August 2006
Research
Macrolide Resistance in Adults with Bacteremic Pneumococcal Pneumonia
Joshua P. Metlay*†
, Neil O. Fishman†, Marshall M. Joffe†, Michael J. Kallan†, Jesse L. Chittams†, and Paul H. Edelstein†
, Neil O. Fishman†, Marshall M. Joffe†, Michael J. Kallan†, Jesse L. Chittams†, and Paul H. Edelstein†
Table 3
Independent risk factors for macrolide-resistant bacteremic pneumococcal pneumonia*
| Risk factor | OR (95% CI) | p value |
|---|---|---|
| Macrolide <6 mo before infection | 2.8 (1.4–5.8) | 0.005 |
| Influenza vaccination <1 mo before infection | 2.0 (1.2–3.3) | 0.013 |
| Hispanic ethnicity | 4.1 (1.4–12.5) | 0.011 |
| Prior stroke | 0.2 (0.04–0.8) | 0.021 |
*Odds ratio (OR), 95% confidence intervals (CI), and p value from logistic regression with all listed factors in the model.
Page created: December 09, 2011
Page updated: December 09, 2011
Page reviewed: December 09, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.